Biologic Treatments in Adolescents With Moderate-to-Severe Atopic Dermatitis: A Systematic Literature Review and Network Meta-analysis
Although there is some evidence that dupilumab may be more efficacious than lebrikizumab or tralokinumab, our findings suggest that there is no strong evidence of superiority of one treatment over another.
Authors
- Emily K. Duffy (ORCID: https://orcid.org/0000-0001-8079-1479)
- Jonathan A. Luong
- Beth Devine
- Kevin H. Li
Institutions
- University of Washington (US)
- Seattle Children's Hospital (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1177/10600280251415369
- Citations
- 1
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 54.66